We have located links that may give you full text access.
Very Large Diameter Polymer Acetabular Liners Show Promising Wear Simulator Results.
Thinner and larger acetabular components are more stable and are useful for resurfacing. This study performed wear simulator tests of the largest polyurethane (PUR) and highly cross-linked polyethylene (XLPE) liners available. The results were compared with conventional polyethylene (ConvPE) to determine wear, survivorship, wear debris particles generated, and oxidative degradation. Two-piece acetabular components with a 4-mm poly liner, a 2-mm metal backing, and 1 mm of porous coating with an inner diameter of 51 mm were tested. Cobalt chromium (CoCr) and titanium nitride (TiN)-coated titanium- resurfacing femoral components were counter-face surfaces. Acetabular components were tested at 45° and 65° inclinations, with both 300 μm and an increase of 1 mm in radial clearance. After 30 million cycles, PUR had 56% (p < 0.001) less wear and cross-linked had 93% (p < 0.001) less wear than ConvPE. TiN-coated femoral implants had 23% less wear than CoCr when used with cross-linked polyethylene. Wear increased by 16% at 65° and by 19% when radial clearance increased with cross-linked polyethylene. Polymethylmethacrylate debris ultimately failed ConvPE, but not the cross-linked polyethylene or PUR. XLPE acetabular liners are compatible with >20 years of expected use in active patients.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app